Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Flavone acetic acid and plasma protein binding.

J Brodfuehrer1, F Valeriote, K Chan

  • 1Department of Internal Medicine, Wayne State University, Detroit, MI 48201.

Cancer Chemotherapy and Pharmacology
|January 1, 1990
PubMed
Summary

Flavone acetic acid (FAA) exhibits greater plasma protein binding in humans than in mice, influenced by albumin concentration. Albumin levels and nonlinear binding impact FAA

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measurement of the charge asymmetry in top quark pair production in <i>pp</i> collisions at [Formula: see text] using the ATLAS detector.

The European physical journal. C, Particles and fields·2015
Same author

Search for lepton flavour violation in the <i>eμ</i> continuum with the ATLAS detector in [Formula: see text]<i>pp</i> collisions at the LHC.

The European physical journal. C, Particles and fields·2015
Same author

Measurement of [Formula: see text] production with a veto on additional central jet activity in <i>pp</i> collisions at [Formula: see text] TeV using the ATLAS detector.

The European physical journal. C, Particles and fields·2015
Same author

Measurement of the top quark mass with the template method in the [Formula: see text] channel using ATLAS data.

The European physical journal. C, Particles and fields·2015
Same author

Search for heavy neutrinos and right-handed <i>W</i> bosons in events with two leptons and jets in <i>pp</i> collisions at [Formula: see text] with the ATLAS detector.

The European physical journal. C, Particles and fields·2015
Same author

Strategies of sequential therapies in unresectable metastatic colorectal cancer: a meta-analysis.

Current oncology (Toronto, Ont.)·2014

Area of Science:

  • Pharmacology
  • Biochemistry
  • Drug Metabolism

Background:

  • Plasma protein binding is crucial for drug efficacy and disposition.
  • Flavone acetic acid (FAA) is an anticancer agent whose pharmacokinetics require detailed understanding.
  • Variations in plasma protein binding can lead to differential drug effects.

Purpose of the Study:

  • To investigate the binding capacity and characteristics of flavone acetic acid (FAA) to plasma proteins in healthy humans, cancer patients, and mice.
  • To determine the influence of albumin concentration on FAA binding.
  • To identify the specific binding site of FAA on albumin.

Main Methods:

  • Plasma protein binding assays were performed using healthy human, cancer patient, and mouse plasma.
  • Albumin concentration was measured in all plasma samples.

Related Experiment Videos

  • Scatchard analysis was employed to characterize binding sites.
  • Displacement studies were conducted using salicylic acid and clofibric acid.

    • Main Results:

    • FAA binding to plasma proteins was significantly higher in humans (healthy and cancer patients) compared to mice.
    • Plasma from cancer patients bound less FAA than plasma from healthy individuals.
    • FAA binding correlated with plasma albumin concentration, but albumin alone did not fully predict binding.
    • Healthy human plasma exhibited more high-affinity binding sites than mouse plasma.
    • FAA binds to the indolebenzodiazepine site on albumin, displaceable at high concentrations.

    Conclusions:

    • Alterations in plasma albumin concentration can contribute to variable effects of FAA.
    • The nonlinear nature of FAA protein binding and serum albumin levels are important considerations for optimizing FAA dosing.
    • Understanding species-specific and patient-specific protein binding is essential for effective flavone acetic acid therapy.